西他列汀 | CAS:486460-32-6 | 福来兹-品类齐全、品质保障、配送及时、畅选无忧

中文名称:	西他列汀
英文名称:	Sitagliptin
CAS.No:	486460-32-6	CAS 相关:	西他列汀;(3R)-3-氨基-1-[3-(三氟甲基)-5,6,7,8-四氢-1,2,4-三唑并[4,3-a]吡嗪-7-基]-4-(2,4,5-三氟苯基)丁-1-酮;Sitagliptin 西他列汀;磷酸西他列汀;磷酸西他列汀（碱）;西格列汀;西他列汀-D4;西他列汀标准品及杂质;西他列汀碱;西他列汀游离碱;西他列汀杂质;西他列汀杂质对照品;二甲双胍+SITAGLIPTIN,复方;西格列汀杂质
MDL No:
分子式:	C₁₆H₁₅F₆N₅O
分子量:	407.32	密度:
熔点:		沸点:
储藏条件:
危险安全标识:

中文名称:

西他列汀

英文名称:

Sitagliptin

CAS.No:

486460-32-6

CAS 相关:

西他列汀;(3R)-3-氨基-1-[3-(三氟甲基)-5,6,7,8-四氢-1,2,4-三唑并[4,3-a]吡嗪-7-基]-4-(2,4,5-三氟苯基)丁-1-酮;Sitagliptin 西他列汀;磷酸西他列汀;磷酸西他列汀（碱）;西格列汀;西他列汀-D4;西他列汀标准品及杂质;西他列汀碱;西他列汀游离碱;西他列汀杂质;西他列汀杂质对照品;二甲双胍+SITAGLIPTIN,复方;西格列汀杂质

MDL No:

分子式:

C₁₆H₁₅F₆N₅O

分子量:

407.32

密度:

熔点:

沸点:

储藏条件:

危险安全标识:

* 如果需要咨询更多不同包装的价格，请您联系客服为您查询报价。
* 订购成功后，将从离您最近的仓库发货，如果其中一个仓库中库存不足，我们将从另外一个仓库发货以减少交货时间。

中文名称：: 西他列汀

中文别名：: 西他列汀;(3R)-3-氨基-1-[3-(三氟甲基)-5,6,7,8-四氢-1,2,4-三唑并[4,3-a]吡嗪-7-基]-4-(2,4,5-三氟苯基)丁-1-酮;Sitagliptin 西他列汀;磷酸西他列汀;磷酸西他列汀（碱）;西格列汀;西他列汀-D4;西他列汀标准品及杂质;西他列汀碱;西他列汀游离碱;西他列汀杂质;西他列汀杂质对照品;二甲双胍+SITAGLIPTIN,复方;西格列汀杂质

英文名称：: Sitagliptin

英文别名：: Sitagliptin;(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;Sitagliptin intermediate;Sitagliptin phosphate monohydrate;(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-riazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-rifluorophenyl);C16H15F6N5O;Sitagliptin Phosphate(free base);Janumet;MK0431;MK-0431;Unii-qfp0p1dv7z;Sitagliptin IMpurity;Januvia;Xelevia;Sitagliptin phosphate;Sitagliptan;Tesavel;QFP0P1DV7Z;(3R)-3-AMINO-1-[3-(TRIFLUOROMETHYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE;(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE;(R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE;(3;(3R)-3-Amino-1-;1,2,4-Triazolo[4,3-a]pyrazine,7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-;WHO 8692;(3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;(3R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one;BSPBio_002262;NCGC00178734-03;AB01563393_01;MLS006011959;NCGC00178734-06;1,2,4-TRIAZOLO(4,3-A)PYRAZINE-7(8H)-PROPANAMINE, 5,6-DIHYDRO-.GAMMA.-OXO-3-(TRIFLUOROMETHYL)-.ALPHA.-((2,4,5-TRIFLUOROPHENYL)METHYL)-, (.ALPHA.R)-;(3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,4-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one hydrochloride;sitagliptinum;NS00000425;EX-A2816;Sitagliptin [INN];SITAGLIPTIN [WHO-DD];MFCD09838015;Z1521553713;SITAGLIPTIN [VANDF];DB01261;(2r)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a] pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine;LEZ763;486460-32-6;SITAGLIPTIN [HSDB];(R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine;(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-A MINE;HMS2093F20;BDBM11162;CHEMBL1422;SITAGLIPTIN [EMA EPAR];Sitagliptin; MK0431;SITAGLIPTIN [MI];EN300-119510;Q-201711;AR-270/43507782;SR-05000001748;(2R)-4-oxo-4-;1x70;BRD-K19416115-001-01-2;1,2,4-TRIAZOLO(4,3-A)PYRAZINE-7(8H)-PROPANAMINE, 5,6-DIHYDRO-gamma-OXO-3-(TRIFLUOROMETHYL)-alpha-((2,4,5-TRIFLUOROPHENYL)METHYL)-, (alphaR)-;GTPL6286;AS-19118;(2r)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-a;(1R)-3-oxo-3-[3-(trifluoroethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorobenzyl)propylamine;NSC813215;A25516;3-oxo-1-(2,4,5-trifluorobenzyl)-3-(3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)propylamine;sitagliptine...